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Abstract 
Background: Chemokines are attractive candidates for vaccine adjuvants due to their ability to recruit the immune 
cells. Lactic acid bacteria (LAB)-based delivery vehicles have potential to be used as a cheap and safe option for vac-
cination. Chemokine produced on the surface of LAB may potentially enhance the immune response to an antigen 
and this approach can be considered in development of future mucosal vaccines.
Results: We have constructed strains of Lactobacillus plantarum displaying a chemokine on their surface. L. plan-
tarum was genetically engineered to express and anchor to the surface a protein called CCL3Gag. CCL3Gag is a fusion 
protein comprising of truncated HIV-1 Gag antigen and the murine chemokine CCL3, also known as MIP-1α. Various 
surface anchoring strategies were explored: (1) a lipobox-based covalent membrane anchor, (2) sortase-mediated 
covalent cell wall anchoring, (3) LysM-based non-covalent cell wall anchoring, and (4) an N-terminal signal peptide-
based transmembrane anchor. Protein production and correct localization were confirmed using Western blotting, 
flow cytometry and immunofluorescence microscopy. Using a chemotaxis assay, we demonstrated that CCL3Gag-
producing L. plantarum strains are able to recruit immune cells in vitro.
Conclusions: The results show the ability of engineered L. plantarum to produce a functional chemotactic protein 
immobilized on the bacterial surface. We observed that the activity of surface-displayed CCL3Gag differed depending 
on the type of anchor used. The chemokine which is a part of the bacteria-based vaccine may increase the recruit-
ment of immune cells and, thereby, enhance the reaction of the immune system to the vaccine.
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Background
Chemokines are a group of small (7–12  kDa) proteins 
important in both homeostatic and inflammatory con-
ditions. They are essential molecules in inflammation 
and immunity because of their ability to recruit immune 
cells [1–4]. Based on the arrangement of conserved 
cysteine residues, chemokines are divided into four dif-
ferent groups: CXC, CC, CX3C, and XC [5]. The ter-
tiary structure of chemokines is highly conserved where 
the N-terminal domains of chemokines are essential for 
chemokine receptor activation [6, 7]. Chemokines may 
organize into dimers or oligomers and there is a large 
variety in oligomeric forms and in the tendency to oli-
gomerize [7–10]. Because of their ability to recruit the 
immune cells, chemokines are attractive candidates for 
vaccine adjuvants and have indeed been used as such 
with considerable success [11–13].
The chemokine CCL3, also known as macrophage 
inflammatory protein-1 alpha (MIP-1α) is produced 
by various types of cells and interacts with CCR1 and 
CCR5 receptors expressed by dendritic cells (DCs) 
and macrophages (i.e. antigen-presenting cells), natu-
ral killer cells, as well as CD4+ and CD8+ T cells [14]. It 
has previously been demonstrated that co-administra-
tion of antigens and CCL3 or fusion of antigen to CCL3 
increased the antigen-specific CD8+ T cell responses to 
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for example influenza and HIV-1 [15–19]. Furthermore, 
a recent report showed that CCL3 was necessary (but not 
sufficient) for tumor rejection and efficient DCs migra-
tion to lymph nodes [20].
The use of bacteria as vaccine delivery vehicles is a 
very promising strategy for mucosal vaccination. Non-
pathogenic food grade bacteria, in particular lactic acid 
bacteria (LAB), are promising candidates due to their 
safe status and the simplicity of genetic engineering [21]. 
Many species from the Lactobacillus genus interact with 
epithelial cells by binding to pattern recognition recep-
tors (PRRs) [22]. Moreover, it has been shown that some 
lactobacilli interact with DCs and thereby regulate T 
cell responses [23]. It is well known that Lactobacillus 
spp. have immunostimulatory properties that may vary 
between strains [24]. Because of their immunostimula-
tory properties, lactobacilli themselves are considered 
as potential vaccine adjuvants. For example, it has been 
shown that heat-killed L. casei functioned as an efficient 
adjuvant in combination with a nasal vaccine against 
Steptococcus pneumoniae [25]. In recent years, significant 
progress has been made in developing LAB as delivery 
vehicles for mucosal vaccines and therapeutic biomol-
ecules [21, 26–29].
Despite three decades of massive research there is still 
no vaccine for human immunodeficiency virus type 1 
(HIV-1) and the vaccine development remains a global 
priority. Protection against HIV-1 will likely depend on 
virus-specific antibodies, but a CD8+ T cells response, 
leading to elimination of infected cells, is also considered 
highly important [30]. The use of LAB as delivery host 
for a mucosal vaccine against HIV-1 has previously been 
shown to induce HIV-1 specific immune responses. Ani-
mal studies with an orally administrated L. lactis strain 
producing surface-anchored HIV-1 envelope protein 
induced effective and specific immunity in mice [31]. 
Likewise, L. acidophilus displaying the Gag antigen of 
HIV-1 elicited specific immune responses in  vitro and 
in vivo [32].
In the present study, we have explored the possibil-
ity to express CCL3 together with a truncated HIV-1 
Gag antigen in L. plantarum with the aim of increasing 
the recruitment of immune cells. We selected the Gag 
antigen since it is one of the most common and most 
immunogenic HIV-1 antigens [33–35] and because it 
was known that expression in Lactobacillus cells is pos-
sible and can lead to a specific immune response [32]. We 
fused CCL3 to Gag and exploited various Lactobacillus 
plantarum-derived surface anchoring domains in order 
to display the CCL3Gag fusion protein on the bacterial 
surface. Then we analyzed whether the fusion protein 
was correctly displayed at the exterior of the cell after 
which the chemotactic properties of bacteria producing 
CCL3Gag were investigated. We show that most of the 
recombinant strains indeed are able to recruit T cells 
in  vitro and that biological activity of the chemotac-
tic protein depends on the type of anchor used. To our 
knowledge, this is the first study showing the ability of an 
engineered Lactobacillus to produce a functional chemo-
tactic protein immobilized on its surface.
Results
Construction of L. plantarum for display of the CCL3Gag 
fusion protein
Five different expression vectors were generated as 
described in the Materials and Methods section, with 
architectures outlined in Fig. 1. In all constructs, the Gag 
antigen was fused to the C-terminal end of CCL3, result-
ing in fusion protein CCL3Gag. CCL3Gag was linked to 
the bacteria via a C-terminal anchor (Fig.  1a) and four 
different N-terminal anchors (Fig.  1b). The C-terminal 
anchor was fused to the C-terminal end of CCL3Gag, 
consequently, CCL3 is expected to protrude from the 
bacteria after surface localization. For the constructs with 
N-terminal anchors, the Gag sequence forms the C-ter-
minal part and is expected to protrude from the bacte-
ria. The C-terminal anchor is a covalent cell wall anchor 
(Cwa) derived from Lp_2578 containing an LPxTG 
domain that ensures sortase-catalyzed covalent binding 
to peptidoglycan. We used four N-terminal anchoring 
sequences of different nature: (1) a non-covalent anchor 
derived from Lp_3014 encoding a LysM domain with 
affinity for peptidoglycan, (2) two lipoprotein anchors 
derived from Lp_1261 and Lp_1452 which attach the 
target protein covalently to the cell membrane, and (3) 
a transmembrane anchor (a non-cleaved signal peptide) 
derived from Lp_1568. L. plantarum transformed with 
pEV, an empty plasmid lacking the sequence encoding 
CCL3Gag [36], was used as negative control (referred to 
as Lp_Ev).
Production of anchor‑fused CCL3Gag protein
Expression of the gene encoding the hybrid proteins was 
induced by adding a peptide pheromone to the grow-
ing cultures of the recombinant L. plantarum strains. 
In order to examine whether CCL3Gag was produced, 
crude protein extracts from induced strains were sub-
jected to Western blotting using an anti-CCL3 antibody. 
The fusion of CCL3 and Gag has a molecular weight of 
22  kDa, whereas the sizes of the anchors vary. Figure  2 
shows bands with the expected masses for all CCL3Gag 
producing strains. In some of the extracts, putative 
breakdown products are also visible. As expected, no 
bands were observed in the protein extract of the nega-
tive control. Thus, the hybrid proteins were successfully 
produced by L. plantarum.
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Growth characteristics of CCL3Gag‑expressing  
L. plantarum strains
We investigated whether expression and secretion of the 
heterologous proteins may be stressful and reduce the 
growth of the recombinant L. plantarum. Figure 3 shows 
that the non-induced recombinant strains engineered 
for CCL3Gag production had similar growth rates as 
the strain containing the empty vector. Upon induc-
tion, clear growth retardation was observed for strains 
harboring pLp_1452CCL3Gag, pLp_1568CCL3Gag, 
and, to a lesser extent, pLp_CCL3Gag_Cwa. The growth 
of induced strains harboring pLp_3014CCL3Gag or 
pLp_1261CCL3Gag differed only slightly from the 
growth of the non-induced and control cultures (Fig. 3). 
Interestingly, the effect of induction on growth was 
dependent on the anchor used and the growth effects 
observed here show similar tendencies as in a previous 
study using the same anchoring sequences [36]. Notably, 
all strains did grow upon induction and Fig. 2 shows that 
the CCL3Gag was produced.
Surface display of CCL3 in L. plantarum
In order to confirm the surface localization of the 
CCL3Gag protein, we carried out flow cytometry analysis 
and fluorescence microscopy, by labeling of live bacteria 
with an anti-CCL3 antibody (Fig.  4). The flow cytom-
etry analysis showed a clear increase of fluorescence 
intensity for Lp_CCL3Gag_Cwa, Lp_3014CCL3Gag, 
Lp_1452CCL3Gag and Lp_1261CCL3Gag, compared to 
the negative control, suggesting surface localization of 
the CCL3Gag protein (Fig. 4a). Notably, the results show 
substantial differences between the individual strains. 
For the strain producing the transmembrane-anchored 
version of CCL3Gag (Lp_1568CCL3Gag), the fluores-
cence intensity was not substantially different from the 
negative control (Fig.  4a). Fluorescence microscopy 
(Fig. 4b) showed the strongest signals for strains in which 
CCL3Gag is attached to the cell wall (Lp_CCL3Gag_Cwa 
and Lp_3014CCL3Gag). These strains also gave the high-
est fluorescence intensity in flow cytometry (Fig.  4a). 
Interestingly, we observed differences in fluorescence 
intensity for the two strains producing CCL3Gag with 
lipoprotein anchors. Both in flow cytometry and in fluo-
rescence microscopy Lp_1452CCL3Gag showed higher 
fluorescence intensity compared to Lp_1261CCL3Gag.
Effect of surface displayed CCL3 on chemotaxis
To determine whether CCL3 showed biological activ-
ity when fused to Gag and surface-attached by L. plan-
tarum, we tested the bacteria in a chemotaxis assay with 
a murine T cell line. The cell line is denoted Esb-MP and 
expresses the CCL3 receptors CCR1 and CCR5 [37, 38]. 
As positive and negative controls, we used free recombi-
nant murine CCL3 and Lp_Ev, respectively.
In an initial experiment, we examined the chemotactic 
activity of Lp_CCL3Gag_Cwa strain, in which CCL3Gag 
Fig. 1 The expression cassette for C-terminal (a) and N-terminal (b) anchoring of CCL3Gag in L. plantarum. All parts of the cassette are easily 
exchangeable using restriction sites: SalI between the signal peptide or the N-terminal anchor and CCL3Gag, EcoRI, at the end of the insert, and MluI 
between CCL3Gag and the C-terminal anchor. a C-terminal anchoring was accomplished by fusing the N-terminus of the CCL3Gag fragment to a 
signal peptide (SP; from Lp_0373) and the C-terminus to a cell wall anchor (Cwa) from Lp_2578 (Cwa comprises 194 residues of Lp_2578) [42]. b 
Four N-terminal anchoring motifs were used, all containing an SP. Two lipoanchors were generated using lipobox fragments from Lp_1261 (residues 
1–75) and Lp_1452 (residues 1–142), one transmembrane anchor was generated by fusing CCL3Gag to C-terminally truncated Lp_1568 (complete 
protein with 7-residues truncation), which contains an SP without a predicted signal peptide cleavage site, and one LysM anchor was generated by 
fusing CCL3Gag to full length Lp_3014 (a 204 residue putative transglycosylase with an N-terminal LysM domain)
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is covalently attached to the cell wall, i.e. the most outer 
part of the bacteria, and in which the N-terminal domain 
of CCL3, essential for chemotaxis activation, is likely to 
be the most external part of the surface-coupled protein. 
Figure 5a shows that this strain indeed was able to attract 
T cells. The number of migrated cells towards bacteria 
displaying CCL3 was nearly fourfold higher compared to 
the negative control strain. This result shows that CCL3 
localized on the surface of L. plantarum is biologically 
active.
In the next step, we tested chemotactic functionality 
of the four strains producing CCL3Gag protein fused to 
N-terminal anchors. These experiments suffered from 
rather large variations in the counts of migrated cells, 
but did consistently indicate that all strains, except 
Lp_1261CCL3Gag, promote increased recruitment of 
Esb-MP cells relative to the negative control (Fig.  5b). 
The variations between independent experiments were 
too high to determine statistical significance. The fact 
that Lp_1261CCL3Gag showed the lowest levels of sur-
face accessible protein (Fig. 4) and caused no chemotaxis 
(Fig. 5b) may be taken to add confidence to the data. On 
the other hand, however, Lp_1568CCL3Gag did consist-
ently cause chemotaxis, whereas no signals were obtained 
in flow cytometry and fluorescence microscopy.
The chemotactic activity of surface-displayed CCL3, 
particularly when N-terminally anchored, may be ham-
pered by steric constraints caused by the fusion with 
an anchor and Gag, and/or by a cell wall embedded 
localization masking interacting regions of the protein. 
Likewise, the oligomerization of CCL3, which contrib-
utes to activity [7], is likely to be restricted by the sur-
face immobilization. We hypothesized that addition 
of soluble CCL3 in amounts that are too low to cause 
full chemotaxis could enhance chemotaxis caused by 
the CCL3Gag-displaying bacteria. Therefore, we car-
ried out chemotaxis experiments where we added low 
concentrations (3  ng/ml) of CCL3 to bacteria express-
ing CCL3Gag and to the negative control strain. As 
expected, the presence of free CCL3 in the bacterial 
suspension led to cell migration for all strains (includ-
ing the negative control; data not shown). There were, 
however, significant differences in degree of chemotaxis 
between the negative control and all CCL3Gag-pro-
ducing strains, except Lp_1261CCL3Gag (Fig.  6). For 
three strains, Lp_1452CCL3Gag, Lp_1568CCL3Gag and 
Lp_CCL3Gag_Cwa, the Esb-MP migration was approxi-
mately fourfold higher (compared to Lp_Ev), whereas the 
fold change for Lp_3014CCL3Gag was below two.
To exclude positive or negative effects of L. plantarum 
itself on chemotaxis, we performed the chemotaxis assay 
with control strain Lp_Ev in the absence and presence of 
the low concentration (3 ng/ml) of CCL3 and compared 
with a set-up without added bacteria at all (only T cell 
medium). The results showed that L. plantarum did not 
exhibit chemotactic properties in the absence of added 
chemokine (Additional file  1a). Moreover, the bacteria 
did not increase chemotaxis induced by 3  ng/ml CCL3 
(Additional file 1b), confirming a lack of natural chemo-
tactic properties.
Discussion
The aim of this study was to analyze the functionality of 
a chemotactic protein displayed on the surface of L. plan-
tarum cells. Surface-display of functional chemokines 
may eventually lead to development of more effective 
LAB-based mucosal vaccines. The results show that 
CCL3Gag was successfully expressed in L. plantarum 
(Fig. 2), that the protein can be detected at the bacterial 
surface in most recombinant strains (Fig.  4), and that 
expression of CCL3Gag indeed promotes chemotaxis 
(Figs. 5, 6). Production of secreted functional chemokines 
Fig. 2 Detection of CCL3Gag fusion protein produced in L. plantarum 
strains harboring various plasmids. Bacterial cell-free protein extracts 
were prepared 3 h after induction by use of peptide pheromone, and 
analyzed by Western blotting, using polyclonal goat anti-CCL3 anti-
body and polyclonal rabbit anti-goat HRP-conjugated IgG. A strain 
harboring the pEV plasmid [36], not containing the ccl3gag fragment, 
was used as a negative control. The following CCL3Gag produc-
ing strains were analyzed (expected mass of the CCL3Gag protein 
between parenthesis): Lp_1452CCL3Gag (39.9 kDa), Lp_1568CCL3Gag 
(95.3 kDa), Lp_3014CCL3Gag (45.0 kDa), Lp_1261CCL3Gag (31.9 kDa), 
Lp_CCL3Gag_Cwa (50.5 kDa). The arrows indicate the location of the 
fusion proteins. Lane M shows a molecular mass standard
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in LAB has been demonstrated before [39–41]. What is 
new here is that we used Lactobacillus, which has a con-
siderably stronger potential as vaccine delivery vehicle 
compared to L. lactis, the bacterium most often used in 
the studies published so far [22]. Furthermore, we used 
surface-display rather than secretion, because proteins 
immobilized on the cell surface are potentially more sta-
ble and more efficiently protected from degradation than 
the secreted protein.
In order to direct the CCL3Gag fusion protein to the 
surface of L. plantarum, we used four different types of 
anchors, previously used for surface display of Invasin 
from Yersinia pseudotuberculosis [36] and an oncofetal 
antigen [42] in Lactobacillus. Some prior studies showed 
that the functionality of heterologous proteins anchored 
to the surface of Lactobacillus strongly depends on the 
type of anchor used. For example, Invasin-expressing L. 
plantarum strains activated NF-κB expression in mono-
cytes to varying levels depending on the anchoring meth-
ods. In this case the two lipo-anchors (from Lp_1261 and 
Lp_1452) worked best whereas the LysM-based anchor 
(from Lp_3014) did not work [36]. Likewise, two L. acido-
philus strains displaying the Salmonella FliC protein with 
two different cell wall anchors showed clear differences in 
terms of their maturating effect on DCs and stimulation 
of cytokine production [43].
It is difficult to answer the question why different 
anchors give different results and why the functionality 
of the to-be-displayed functional protein depends on 
anchor types (note that conclusions on anchor func-
tionality from the previous Invasin study differ from 
the conclusions of this study). For example, weak 
(Lp_1261CCL3Gag; lipoprotein anchor) or minimal 
(Lp_1568CCL3Gag; transmembrane anchor) signals in 
flow cytometry and microscopy may be due to lower pro-
tein production, a more embedded localization in the cell 
wall, or a sub-optimal orientation of the reactive part of 
the displayed protein. In functional studies, in particular 
in vivo studies, proteolytic susceptibility, and stability in 
general, are additional variables. In the two strains giving 
the lowest signal in flow cytometry, the CCL3 is located 
N-terminally, directly following the anchor (Fig.  1b). 
This location may prevent efficient interaction of the 
anti-CCL3 antibody with CCL3 epitopes. Interestingly, 
Lp_1452CCL3Gag gave much stronger signals than the 
other lipoanchor strain, Lp_1261CCL3Gag; in the former 
strain, the anchor sequence is 67 residues longer, which 
could make the CCL3 domain more exposed and acces-
sible to the antibody.
The results of the chemotaxis assays were largely con-
sistent with the results from the flow cytometry and 
microscopy analyses. Convincing data were obtained 
for Lp_CCL3Gag_Cwa, which gave the strongest signal 
in immunofluorescence detection and was clearly able 
to recruit murine T cells in vitro (Fig. 5a). Interestingly, 
in this strain the N-terminal domain of CCL3, which is 
Fig. 3 Growth of CCL3Gag-expressing L. plantarum cells. OD600 values were measured at the induction point (black bars). Next, each culture was 
divided into a pheromone induced culture (white bars) and a non-induced culture (gray bars). OD600 values were measured 3 h after the point of 
induction. The data are presented as the means from triplicates +SD
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essential for interaction with the CCL3 receptor [6, 44, 
45], is likely to be highly exposed (Fig.  1a). In the four 
remaining strains, the N-terminal chemokine domain is 
likely to be less exposed (Fig.  1b). The chemotaxis data 
for these strains varied between each experiment, but 
showed consistent trends, suggesting that all strains 
except Lp_1261CCL3Gag and the negative control 
induce chemotaxis.
Migration of chemoattracted cells is always preceded 
by receptor activation through direct interaction with 
the chemokine [6, 44]. Such receptor binding is often 
stimulated by formation of higher protein structures, 
such as dimers or oligomers [7, 8]. This process is likely 
hampered for surface anchored and possibly embedded 
CCL3Gag. We showed that free soluble CCL3 protein, 
added at a concentration that is clearly suboptimal for full 
activity (according to the supplier), promoted increased 
chemotaxis for Lp_CCL3Gag_Cwa, Lp_1452CCL3Gag, 
Lp_3014CCL3Gag, Lp_1568CCL3Gag relative to the neg-
ative control strain (Fig. 6). For the Lp_1261 lipoprotein 
Fig. 4 Flow cytometry (a) and microscopy (b) analysis of surface localization of CCL3Gag. L. plantarum cells harboring plasmids designed for N- or 
C-terminal anchoring of CCL3Gag were probed with goat anti-CCL3 polyclonal antibody and, subsequently, Alexa Fluor®488-conjugated rabbit 
anti-goat IgG antibodies. L. plantarum harboring pEV without the ccl3gag gene fragment was used as a negative control and is shown in all five his-
tograms in panel a (black line). The data are presented as one representative experiment. Each experiment was performed at least three independ-
ent times and gave the similar results
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anchor the fluorescence signal was weak and the strain 
did not induce chemotactic activity, which suggests 
either not sufficient surface display of CCL3 or that the 
displayed CCL3 lacks biological activity. Generally, in all 
experiments, we used similar amounts of bacterial cells, 
but it should be noted that the number of proteins at the 
surface might differ between the recombinant strains, 
which of course will influence strain functionality.
Importantly, the current results indicate that the 
translational fusion between CCL3 and the Gag antigen 
did not abolish the functionality of the chemokine. The 
biological activity of CCL3 fused to other proteins has 
been determined for fusions with a tumor antigen [46], 
HIV-1 gp-120 [17], mCherry fluorescent protein [47], 
and hemagglutinin from influenza virus [48]. In these 
prior studies, the fusion protein was tested in free solu-
ble form, and not in an immobilized form as was done 
here. In this regard, it was important to check whether 
the observed chemotaxis really was an effect of protein 
immobilized on the bacterial cell, and not a result of free 
protein released as an effect of bacterial lysis and pro-
tein degradation, or by shedding from the surface. In a 
Fig. 5 Chemotactic properties of L. plantarum harbouring various constructs. The graphs show migration of Esb-MP cells towards CCL3Gag-
expressing strains compared to migration towards the negative control (Lp_Ev). The number of migrated cells was counted using flow cytometry 
and relative chemotaxis is shown as the average fold change relative to the negative control. a L. plantarum strain displaying CCL3Gag anchored 
C-terminally to the surface. The data presented are the means from 3 replicates +SEM. Statistically significant differences compared to the negative 
control (p < 0.01) are indicated by an asterisk (*). b L. plantarum strains displaying CCL3Gag anchored N-terminally to the surface. The data presented 
are derived from one representative experiment. The experiments were performed at least three times and these independent experiments 
showed the similar trends
Fig. 6 Chemotactic properties of L. plantarum strains surface dis-
playing CCL3Gag, in presence of soluble CCL3 protein. Migration of 
Esb-MP cells towards CCL3Gag expressing strains in the presence of 
3 ng/ml free CCL3 was compared to migration towards the negative 
control (Lp_Ev). The number of migrated cells was counted using flow 
cytometry and relative chemotaxis is shown as average fold change 
relative to the negative control. The data are presented as the means 
from at least 5 replicates +SEM. Statistically significant differences 
(p < 0.01) are indicated by an asterisk (*)
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control experiment, we collected the cell-free superna-
tants from a chemotaxis experiment and analyzed these 
by Western blotting. Very weak bands were detected only 
for Lp_1261CCL3Gag and Lp_3014CCL3Gag, which are 
among the variants causing no or little chemotaxis (data 
not shown). Importantly, no soluble protein was detected 
in experiments with the best performing strain, Lp_
CCL3Gag_Cwa. So, it seems that the observed chemot-
axis is not due to released soluble protein, although this 
cannot be excluded for Lp_3014CCL3Gag.
Conclusion
The present study shows that L. plantarum NC8 was 
able to produce a fusion protein consisting of a murine 
chemokine, CCL3, and a truncated HIV-1 Gag anti-
gen, and to display the protein on the bacterial sur-
face. Chemotaxis assays demonstrated that the CCL3 
domain was functional, albeit to varying extents that 
depended on the type of anchor used. The fusion of 
the Gag antigen with CCL3 may constitute a valuable 
approach in development of a HIV-1 vaccine. Further 
work to verify the validity of this approach is currently 
considered.
Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study 
are listed in Table  1. Lactobacillus plantarum strains 
were cultured in MRS broth (Oxoid Ltd., Basingstoke, 
UK) at 37  °C without shaking. Escherichia coli TOP10 
cells (Invitrogen, Carlsbad, CA, USA) were grown in 
Brain Heart Infusion (BHI, Oxoid) broth and incu-
bated at 37 °C with shaking. Erythromycin was added to 
final concentrations of 10  µg/ml for L. plantarum and 
200 µg/ml for E. coli. Liquid medium was solidified by 
adding 1.5 % (w/v) agar.
Table 1 Strains and plasmids used in this study
Strain or plasmid Description References
Plasmids
 pUC-CCL3Gag Ampr; pUC57 vector with synthetic ccl3gag gene Genescript
 pEV Eryr; control plasmid (“empty vector”) [36]
 pLp_1261Inv Eryr; pLp_2588sAmyA [51] derivative, encoding a lipoanchor sequence from lp_1261 fused  
to a fragment of an invasin encoding gene; for anchoring through an N-terminal lipobox.
[36]
 pLp_1452Inv Eryr; as pLp_1261Inv, but with the lipoanchor from Lp_1452. [36]
 pLp_3014Inv Eryr; pLp_2588sAmyA [51] derivative, encoding Lp_3014 fused to the a fragment of an invasin  
encoding gene; for anchoring through an N-terminal LysM domain.
[36]
 pLp_1568InvS Eryr; pLp_2588sAmyA [51] derivative, encoding Lp_1568 fused to a fragment of an invasion  
encoding gene; for N-terminal anchoring through a signal peptide-like transmembrane helix.
[36]
 pLp_0373sOFAcwa2 Eryr; pLp_0373sNuc [51] derivative, encoding signal peptide sequence from Lp_0373 fused to  
the ofa gene and a subsequent anchor encoding sequence (cwa2); for C-terminal  
covalent anchoring to the cell wall.
[42]
 pLp_1261_CCL3Gag Eryr, pLp_1261Inv derivative, where inv gene fragment has been replaced by the ccl3gag fusion gene. This study
 pLp_1452_CCL3Gag Eryr, pLp_1452Inv derivative, where inv gene fragment has been replaced by the ccl3gag fusion gene. This study
 pLp_3014_CCL3Gag Eryr, pLp_3014Inv derivative, where inv gene fragment has been replaced by the ccl3gag fusion gene. This study
 pLp_1586_CCL3Gag Eryr, pLp_1568InvS derivative, where inv gene fragment has been replaced by the ccl3gag fusion gene This study
 pLp_CCL3Gag_Cwa Eryr, pLp_0373sOFAcwa2 derivative, where the ofa gene has been replaced by the ccl3gag fusion gene This study
Strains
 L. plantarum NC8 Host strain [55]
 E. coli TOP10 Host strain Invitrogen
 Lp_1261CCL3Gag L. plantarum NC8 harboring pLp_1261CCL3Gag; for surface display of the CCL3Gag protein using an N-terminal 
lipo-anchor
This study
 Lp_1452CCL3Gag L. plantarum NC8 carrying pLp_1452CCL3Gag; for surface display of the CCL3Gag protein using an N-termina 
lipo-anchor
This study
 Lp_3014CCL3Gag L. plantarum NC8 carrying pLp_3014CCL3Gag; for surface display of the CCL3Gag protein using an N-terminal 
LysM domain
This study
 Lp_1568CCL3Gag L. plantarum NC8 carrying pLp_1568CCL3Gag; for surface display of the CCL3Gag protein using an N-terminal 
transmembrane anchor
This study
 Lp_CCL3Gag_Cwa L. plantarum NC8 carrying pLp_CCL3Gag_Cwa; for surface display of the CCL3Gag protein using a C-terminal 
covalent cell wall anchor (Cwa)
This study
 Lp_Ev L. plantarum NC8 carrying pEV (emtpy vector); used as a negative control strain [36]
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DNA manipulations and plasmid construction
The primers used in this study are listed in Table  2. All 
expression plasmids used in this study are derivatives of 
the pSIP400 vector, constructed and developed for induc-
ible gene expression, secretion and surface anchoring of 
proteins in Lactobacillus spp [42, 49–51]. For practical 
reasons, pSIP400 derivatives encoding a bacterial invasin 
[36] or oncofecal antigen [42] fused to the diverse anchors 
were used as starting point for cloning. The gene construct 
for the fusion protein was such that the C-terminal end 
of CCL3 [GenBank: NP_035467] was fused to an antigen 
derived from group specific antigen (Gag) of HIV-1 iso-
late HXB2 [52] without a linker. The antigen part in this 
study is denoted Gag and covered amino acids 192–315 
of Gag [GenBank: AAB50258.1], which comprises major 
determinants of immunogenicity including the MHC class 
I (H-2 Kd)-restricted peptide AMQMLKETI. The ccl3gag 
gene fragment was codon optimized for expression in L. 
plantarum, synthesized at Genscript (Piscataway, NJ) and 
cloned into a pUC57 plasmid, yielding pUC-CCL3Gag. 
The pUC-CCL3Gag plasmid was digested with SalI and 
EcoRI and the ccl3gag fragment was ligated into SalI/EcoRI 
digested pLp_1452Inv, pLp_1261Inv and pLp_3014Inv 
plasmids, yielding the plasmids pLp_1452CCL3Gag, 
pLp_1261CCL3Gag and pLp_3014CCL3Gag, respectively. 
A sequence encoding the N-terminal part of Lp_1568 was 
amplified from pLp_1568Inv, using primers 1568F and 
1568R, and inserted to pLp_1261CCL3Gag, digested with 
NdeI and SalI, using In-Fusion®HD Cloning Kit (Clon-
tech Laboratories, Mountain View, CA) yielding the plas-
mid pLp_1568CCL3Gag. Plasmid pLp_0373sOFAcwa2 
was digested with SalI and MluI and ligated by In-Fusion 
cloning to a ccl3gag fragment amplified from pUC–
CCL3Gag using primers cclF and cclR, yielding the plas-
mid pLp_CCL3Gag_Cwa.
All plasmids were first transformed into E. coli TOP10. 
Positive clones were screened by PCR, restriction enzyme 
digestion and sequenced. Purified plasmids were elec-
troporated into L. plantarum cells according to Aukrust 
et al. [53].
Harvesting of strains
Overnight cultures of L. plantarum strains harboring 
plasmids carrying the ccl3gag fusion gene were diluted in 
fresh MRS medium to OD600 ~0.1 and incubated at 37 °C 
until the OD600 reached ~0.3. Recombinant CCL3Gag 
expression was then induced by adding the peptide pher-
omone to a final concentration of 25 ng/ml [54]. Bacterial 
cells were harvested 3 h after induction, unless otherwise 
indicated, by centrifugation at 5000×g, 4  °C, for 5  min. 
Pellets were washed twice with Phosphate Buffered 
Saline (PBS) before using in further experiments. In 
order to determinate the number of colony forming units 
(CFU), harvested bacterial cells were cultivated on solid 
MRS medium supplemented by antibiotic for 24  h and 
the colonies were counted.
Western blotting
To analyze CCL3Gag expression, bacterial cells were 
harvested from 50  ml of cultures, resuspended in 1  ml 
PBS and added to FastPrep tubes containing glass beads 
(Sigma-Aldrich). Cell-free protein extracts were pre-
pared by disruption in a FastPrep® FP120 Cell Disrupter 
by shaking at a speed of 6.5 m/s for 45 s. Cell debris was 
removed by centrifugation at 12,000×g, 4  °C, for 2 min. 
Proteins were separated by SDS–polyacrylamide gel 
electrophoresis and transferred to a nitrocellulose mem-
brane using the iBlot™ Dry Blotting System (Invitrogen). 
Proteins were detected using the SNAP i.d.® 2.0 Protein 
Detection System (Merck kGaA Darmstadt, Germany) 
using a specific polyclonal goat anti-CCL3 antibody 
(R&D Systems, BAF450), 1:10,000 and, subsequently, a 
polyclonal rabbit anti-goat HRP-conjugated (Abcam) 
antibody, diluted 1:5000.
Flow cytometry and indirect immunofluorescence 
microscopy of L. plantarum expressing CCL3Gag
Bacterial strains were harvested as described above. 
Approximately 1 ×  107 CFU were resuspended in 50 µl 
PBS containing 2  % (w/v) bovine serum albumin (BSA, 
Sigma-Aldrich) and 0.4  µl polyclonal goat anti-CCL3 
antibody and incubated for 30 min at room temperature. 
After incubation, cells were centrifuged at 5000×g for 
5 min and washed 4 times with PBS containing 2 % BSA. 
Subsequently, cells were resuspended in 50  µl PBS con-
taining 2 % BSA and polyclonal donkey Alexa Fluor®488 
conjugated anti–goat antibody (Molecular Probes, Life 
technologies, USA) followed by incubation in darkness 
and at room temperature for 30 min. Cells were collected 
by centrifugation, washed 4 times with PBS, and resus-
pended in 100 µl PBS without BSA. The bacterial suspen-
sions were immediately analyzed by flow cytometry using 
a MACSQuant analyzer (Miltenyi Biotec GmbH, Ber-
gisch Gladbach, Germany), following the manufacturer’s 
Table 2 Primers used in this study
a Underlining indicates 15-bp extensions that are complementary to the ends 
of the NdeI/SalI-digested pLp_1261CCL3Gag vector. Overlapping sequences are 
necessary when using In-fusion cloning
b Underlining indicates 15-bp extensions that are complementary to the ends 
of the SalI/MluI-digested pLp_0373sOFAcwa2 vector
Primer Sequence
1568F GGAGTATGATTCATATGAAATTGTTTAAGAAAATTACGATa
1568R CGTATGGGGCGTCGACCGCTGCATAAATTTGCTTAGCAACa
cclF TGCTTCATCAGTCGACGCCCCATACGGTGCTb
cclR GTTCAGTGACACGCGTGTTCTTGACTTCTTGACTCGCTTGTb
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instructions. For indirect immunofluorescence micros-
copy, the bacteria were visualized under a Leica TCS SP5 
Confocal laser scanning microscope (CSLM) using a 488-
nm argon laser for the Alexa Fluor®488 photomultiplier 
tube (PMT) and bright field PMT for transmitted light.
Cell lines
The T-lymphoma cell line Esb-MP was kindly provided 
by Prof. Schirrmacher, (Deutsches Krebsforschungszen-
trum, Heidelberg, Germany). The cells were cultured in 
DMEM medium (Gibco) supplemented with 10  % fetal 
bovine serum (FBS) and antibiotics (Penicillin–Strep-
tomycin, Sigma-Aldrich). Cells were maintained in a 
humidified incubator at 37 °C and 5 % CO2.
CFSE staining
5  mM EDTA in PBS or 0.25  % Trypsin–EDTA (Sigma-
Aldrich) was used to detach the Esb-MP cells from the 
culture flasks (both detachment methods worked equally 
well). The cells were collected by centrifugation at 250 g 
for 8  min at room temperature and washed twice with 
PBS. Subsequently, cells were incubated in PBS with 
5 µM carboxyfluorescein succinimidyl ester (CFSE; Cell-
Trace™ CFSE Cell Proliferation Kit, Molecular Probes, 
Life Technologies) for 30  min at 37  °C, protected from 
light. Stained cells were washed and resuspended in 
RPMI 1640 medium (Gibco) containing 10  % (v/v) FCS 
without antibiotics.
Chemotaxis assay
Approximately 1  ×  108 CFU where used when test-
ing the chemotactic abilities of CCL3Gag-expressing 
L. plantarum. The bacterial pellets, harvested 3  h after 
induction as described above and were either tested in 
chemotaxis assay the same day or were stored at 4  °C 
overnight (no differences in chemotaxis were observed 
upon storage). The bacterial pellets were resuspended in 
600 µl RPMI 1640 medium (Gibco) containing 10 % FCS 
and 20 mM HEPES buffer and placed in the lower wells 
of 24-well 6.5  mm Transwell plates with 0.5  μm pore 
size polycarbonate membrane filters (Transwell® Perme-
able Supports; 5.0 µm polycarbonate membrane; 6.5 mm 
inserts, Corning Incorporated, Corning, NY, USA). In 
some experiments, we modified the chemotaxis assay by 
adding recombinant murine CCL3 (R&D Systems) to the 
bacterial suspensions to final concentrations of 3 ng/ml, 
that were lower than those needed to achieve full chemo-
tactic activity, in order to initiate and enhance chemot-
axis. CCL3 at a concentration of 25 ng/ml in RPMI 1640 
medium with FBS was used as positive control. 2 × 106 
CFSE-labeled Esb-MP cells, resuspended in 100 µl RPMI 
1640 medium with FCS were added to the inserts. The 
plates were incubated in a humidified incubator at 37 °C 
for 2 h. Cells that migrated through the membrane were 
harvested from the lower wells and counted for 5 min by 
fluorescence-activated cell sorting (FACS). Alternatively, 
the total volumes (600  µl) harvested from the lower 
wells and containing migrated cells were counted using 
MACSQuant analyzer, following the manufacturer’s 
instructions.
Statistical analysis
Quantitative experimental data come from replicate (>3) 
experiments and are presented as the means + standard 
deviations (SD) or standard error (SEM). Where relevant, 
the statistical significance of differences (P  <  0.05) was 
determined by using a paired t test.
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